Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease
Open Access
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 10 (1) , 201
- https://doi.org/10.1186/ar2338
Abstract
Activator protein 1 (AP-1) (Fos/Jun) is a transcriptional regulator composed of members of the Fos and Jun families of DNA binding proteins. The functions of AP-1 were initially studied in mouse development as well as in the whole organism through conventional transgenic approaches, but also by gene targeting using knockout strategies. The importance of AP-1 proteins in disease pathways including the inflammatory response became fully apparent through conditional mutagenesis in mice, in particular when employing gene inactivation in a tissue-specific and inducible fashion. Besides the well-documented roles of Fos and Jun proteins in oncogenesis, where these genes can function both as tumor promoters or tumor suppressors, AP-1 proteins are being recognized as regulators of bone and immune cells, a research area termed osteoimmunology. In the present article, we review recent data regarding the functions of AP-1 as a regulator of cytokine expression and an important modulator in inflammatory diseases such as rheumatoid arthritis, psoriasis and psoriatic arthritis. These new data provide a better molecular understanding of disease pathways and should pave the road for the discovery of new targets for therapeutic applications.Keywords
This publication has 48 references indexed in Scilit:
- The relationship between nail- and distal phalangeal bone involvement severity in patients with psoriasisClinical Rheumatology, 2006
- Case of acrodermatitis continua accompanied by psoriatic arthritisThe Journal of Dermatology, 2006
- c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activityGenes & Development, 2006
- Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteinsNature, 2005
- The AP1 transcription factor Fra2 is required for efficient cartilage developmentDevelopment, 2004
- T-cell involvement in osteoclast biology: implications for rheumatoid bone erosionRheumatology, 2003
- Evolving concepts of rheumatoid arthritisNature, 2003
- AP-1 as a regulator of cell life and deathNature Cell Biology, 2002
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002
- Overexpression of fra-2 in transgenic mice perturbs normal eye developmentOncogene, 1998